CAR-T therapy | Xeber World

11:00 · 14 May 2026

CREATE Medicines Secures $122M to Advance CAR-T Therapies for Solid Tumors and Autoimmune Diseases

CREATE Medicines, formerly Myeloid Therapeutics, has raised $122 million to advance its CAR-T therapy pipeline. Co-founded by oncologist Siddhartha Mu...

21:34 · 23 April 2026

How Kelonia Therapeutics’ $3.25B buyout reveals CAR-T’s high-stakes turnaround and drugmakers’ new strategies

Kelonia Therapeutics, a CAR-T biotech on the brink of collapse three times, was acquired by Eli Lilly for $3.25 billion. The deal highlights the secto...

14:40 · 22 April 2026

Medicare Postpones Obesity Drug Coverage Pilot Amid Biotech Updates on RevMed, Roche, and Kyverna CAR-T Therapy

Medicare has delayed a pilot program to cover obesity drugs for seniors, reversing a key healthcare initiative from the Trump administration. This com...

22:45 · 21 April 2026

Kyverna’s Breakthrough Cell Therapy for Stiff Person Syndrome Aims for FDA Approval in 2024

Kyverna Therapeutics has developed a one-time, personalized cell therapy that significantly improved mobility and reduced disabilities in stiff person...